WHO ICTRP trial
A multicenter, prospective, single-arm, phase II clinical trial evaluating the…
ChiCTR2000033066 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000033066 |
|---|---|
| Public title | A multicenter, prospective, single-arm, phase II clinical trial evaluating the efficacy and safety of niraparlib monotherapy for maintenance in patients with recurrent, metastatic intrauterine carcinoma |
| Scientific title | A multicenter, prospective, single-arm, phase II clinical trial evaluating the efficacy and safety of niraparlib monotherapy for maintenance in patients with recurrent, metastatic intrauterine carcinoma |
| Primary sponsor | Zhejiang Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Endometrial carcinoma |
| Interventions | single arm:niraparlib monotherapy |
| Registration date | May 19, 2020 |
| Target size | single arm:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: